The role of low-calorie sweeteners in diabetes

US Endocrinology

Volumn 9, Issue 1, 2013, Pages 13-15

  Johnston, Craig A ^a   Stevens, Brian ^a   Foreyt, John P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Low calorie sweeteners; Type 2 diabetes

Indexed keywords

EID: 84879264247     PISSN: 17583918     EISSN: 17583926     Source Type: Journal    
DOI: 10.17925/use.2013.09.01.13     Document Type: Article

References (64)

1. Danaei G, Finucane MM, Lu Y, et al., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants, Lancet, 2011;378(9785):31-40.
2. International Diabetes Federation, IDF Diabetes Atlas, Brussels: International Diabetes Federation; 2012. Avaialble at: http://www.idf.org/diabetesatlas/5e/the-global-burden
3. Vaz JA, Patnaik A. Diabetes mellitus: Exploring the challenges in the drug development process, Perspect Clin Res, 2012;3(3):109-12.
4. Brown DW, Balluz LS, Giles WH, et al., Diabetes mellitus and health related quality of life among older adults. Findings from Behavioural Risk Factor Surveillance System (BRFSS), Diabetes Res Clin Pract, 2004; 65:105-15.
5. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030, Diabetes Res Clin Pract, 2010;87(3):293-301.
6. Berends LM, Ozanne SE, Early determinants of type- 2 diabetes, Best Prac Res Clin Endocrinol Metab, 2012;26(5):569-80.
7. Imam K, Clinical features, diagnostic criteria and pathogenesis of diabetes mellitus, Adv Exp Med Biol, 2012;771:340-55.
8. Anderson GH, Foreyt J, Sigman-Grant M, Allison DB, The use of low-calorie sweeteners by adults: impact on weight management, J Nut, 2012;142:1163S-9S.
9. Koivula RW, Tornberg AB, Franks PW, Exercise and diabetesrelated cardiovascular disease: systematic review of published evidence from observational studies and clinical trials, Curr Diab Rep, 2013;13(3):372-80.
10. Ramachandran A, Mary S, Yamuna A, et al. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India, Diabetes Care, 2008;31(5):893-8.
11. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulindependent) diabetes mellitus in a population-based cohort of twins in Finland, Diabetologia, 1992;35(11):1060-67.
12. Newman B, Selby JV, King MC, et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins, Diabetologia, 1987;30(10):763-8.
13. Kobberling JTH, Emperical risk figures of first degree relatives of non-insulin dependent diabetes, London: Academic Press, 1982.
14. Sanghera DK, Blackett PR, Type 2 diabetes genetics: beyond GWAS, J Diabetes Metab, 2012;3(198):6948.
15. Gray DS, Diagnosis and prevalence of obesity, Med Clin North Am, 1989;73:1-13.
16. Inadera H, Developmental origins of obesity and type 2 diabetes: molecular aspects and role of chemicals, Environ Health Prev Med, 2013;18(3):185-97.
17. Nasser KA, Gruber A, Thomson GA, The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster?, Int J Clin Pract, 2006;60(9):1093-97.
18. Maggio CA, Pi-Sunyer FX, The prevention and treatment of obesity. Application to type 2 diabetes, Diabetes Care, 1997;20(11):1744-66.
19. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes, JAMA, 2012;308(23):2489-96.
20. de la Hunty A, Gibson S, Ashwell M. A review of the effectiveness of aspartame in helping with weight control, Nutr Bull, 2006;31:115-28
21. Tandel KR, Sugar substitutes: Health controversy over perceived benefits, J Pharmacol Pharmacother, 2011;2:236-43.
22. Artificial sweeteners: no calories.sweet!, FDA Consum.2006;40(4):27-8.
23. Gardana C, Scalianti M, Simonetti P, Evaluation of steviol and its glycosides in Stevia rebaudiana leaves and commercial sweetener by ultra-high-performance liquid chromatographymass spectrometry, J Chromatogr A, 2010;1217(9):1463-70.
24. Fitch C, Keim KS, Academy of Nutrition and Dietetics. Position of the Academy of Nutrition and Dietetics: use of nutritive and nonnutritive sweeteners, J Acad Nutr Diet, 2012;112(5):739-58.
25. Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight, Lancet, 2011;378:826-37.
26. Hill JO, Can a small-changes approach help address the obesity epidemic? A report of the joint task force of the American Society for Nutrition, Institute of Food Technologies, and International Food Information Council, Am J Clin Nutr, 2009;89:1723-8.
27. Hill JO, Wyatt HR, Reed GW, Peters JC, Obesity and environment: where do we go from here?, Science, 2003;299:853-5.
28. Franz MJ, Powers MA, Leontos C, et al. The evidence for medical nutrition therapy for type 1 and type 2 diabetes in adults, J Am Diet Assoc, 2010;110:1852-89.
29. Gardner C, Wylie-Rosett J, Gidding SS, et al. Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association, Circulation, 2012;126:509-19.
30. Espinosa I, Fogelfeld L. Tagatose: from a sweetener to a new diabetic medication?, Expert Opin Investig Drugs, 2010;19(2):285-94.
31. Honkala E, Tala H, Total sugar consumption and dental caries in Europe-an overview, Int Dent J, 1987;37(3):185-91.
32. Gordon Y, Reddy J, Prevalence of dental caries, patterns of sugar consumption and oral hygiene practices in infancy in S. Africa, Community Dent Oral Epidemiol, 1985;13(6):310-14.
33. Cronin A, Periodontal disease is a risk marker for coronary heart disease?, Evid Based Dent, 2009;10(1):22.
34. Trevisan M, Dorn J, The relationship between periodontal disease (pd) and cardiovascular disease (cvd), Mediterr J Hematol Infect Dis, 2010;2(3):e2010030.
35. Mattes RD, Popkin BM, Nonnutritive sweetener consumption in humans: effects on appetite and food intake and their putative mechanisms, Am J Clin Nutr, 2009;89:1-14.
36. Bantle JP, Dietary fructose and metabolic syndrome and diabetes, J Nut, 2009;139(6):1263S-1268S.
37. Hu FB, Malik VS, Sugar-sweetened beeverages and risk of obesity and type 2 diabetes: epidemiologic evidence, Physiol Behav, 2010;100:47-54.
38. Malik VS, Hu FB, Sweeteners and risk of obesity and type 2 diabetes: the role of sugar-sweetened beverages, Curr Diab Rep, 2012;12(2):195-203.
39. Davidson TL, Swithers SE, A pavlovian approach to the problem of obesity, Int J Obes Relat Metab Disord, 2004;28(7):933-5.
40. Stegink LD, Filer LJ, Aspartame: Physiology and Biochemistry. 1st ed, New York, NY: Marcel Dekker, 1984.
41. Bellisle F, Drewnowski A, Anderson GH, et al. Sweetness, satiation, and satiety, J Nutr, 2012;142:1149S-54S.
42. Benton D, Can artificial sweeteners help control body weight and prevent obesity?, Nutr Res Rev, 2005;18:63-76.
43. Blundell JE, Green SM, Effect of sucrose and sweeteners on appetite and energy intake, Int J Obes Relat Metab Disord, 1996;20:(Suppl. 2):S12-17.
44. Drewnowski A, Intense sweeteners and the control of appetite, Nutr Rev, 1995;53:1-7.
45. Drewnowski A, Massien C, Louis-Sylvestre J, et al. Comparing the effects of aspartame and sucrose on motivational ratings, taste preferences, and energy intake in humans, Am J Clin Nutr, 1994;59:338-45.
46. Rolls BJ, Laster LJ, Summerfelt A, Hunger and food intake following consumption of low-calorie foods, Appetite, 1989;13(2):115-27.
47. Van Wymelbeke V, Beridot-Therond ME, de La Gueronniere V, et al. Influence of repeated consumption of beverages containing sucrose or intense sweeteners on food intake, Eur J Clin Nutr, 2004;58:154-61.
48. Anton SD, Martin CK, Han H, et al. Effects of stevia, aspartame, and sucrose on food intake, satiety, and postprandial glucose and insulin levels, Appetite, 2010;55:37-43.
49. Swithers SE, Sample CH, Davidson TL, Adverse effects of high-intensity sweeteners on energy intake and weight control in male and obesity-prone female rats, Behav Neurosci, 2013;127(2):262-74.
50. Stellman SD, Garfinkel L, Artificial sweetener use and one-year weight change among women, Prev Med, 1986;15(2):195-202.
51. Fowler SP, Williams K, Resendez RG, et al. Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain, Obesity, 2008;16(8):1894-900.
52. Hill AB, The environment and disease: association or causation?, Proc R Soc Med, 1965;58(5):295-300.
53. Bellisle F, Drewnowski A, Intense sweeteners, energy intake and the control of body weight, Eur J Clin Nutr, 2007;61(6):691-700.
54. Serra-Majem L, Ribas C, Inglès C, et al. Cyclamate consumption in Catalonia, Spain (1992): relationship with the body mass index, Food Addit Contam, 1996;13(6):695-703.
55. Phelan S, Lang W, Jordan D, Wing RR, Use of artificial sweeteners and fat-modified foods in weight loss maintainers and always-normal weight individuals, Int J Obes (Lond), 2009;33(10):1183-90.
56. Okuno G, Kawakami F, Tako H, et al. Glucose tolerance, blood lipid, insulin and glucagon concentration after single or continuous administration of aspartame in diabetics, Diabetes Res Clin Pract, 1986;2(1):23-7.
57. Mace OJ, Affleck J, Patel N, et al. Sweet taste receptors in rat small intestine stimulate glucose absorption through apical GLUT2, J Physiol, 2007;582:379-92.
58. Renwick AG, Molinary SV, Sweet-taste receptors, low-energy sweeteners, glucose absorption and insulin release, Br J Nutr, 2010;104(10):1415-20.
59. Steinert RE, Frey F, Topfer A, et al. Effects of carbohydrate sugars and artificial sweeteners on appetite and the secretion of gastrointestinal satiety peptides, Br J Nutr, 2011;105:1320-8.
60. Sylvetsky A, Rother KI, Brown R, Artificial sweetener use among children: epidemiology, recommendations, metabolic outcomes, and future directions, Pediatr Clin North Am, 2011;58:1467-80.
61. Garriga MM, Metcalfe DD, Aspartame intolerance, Ann Allergy, 1988;61(6 Pt 2):63-9.
62. Garriga MM, Berkebile C, Metcalfe DD, A combined singleblind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame, J Allergy Clin Immunol, 1991;87(4):821-7.
63. Schiffman SS, Buckley CE, 3rd, Sampson HA, et al. Aspartame and susceptibility to headache, N Engl J Med, 1987;317:1181-5.
64. American Diabetes Association, National Institute of Diabetes, Digestive and Kidney Diseases, The prevention or delay of type 2 diabetes, Diabetes Care, 2002;25(4):742-7.